Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Drug Activity


Published on

Local and Global HEOR Value Propositions/ HTA/PRO QOL/ Clinical and Regulatory Alignment with Reimbursement Needs

Published in: Data & Analytics
  • Be the first to comment

  • Be the first to like this

Drug Activity

  1. 1. SELECTED LIST OF DRUGS: HEOR VALUE PROPOSITION STUDIES/ HTA GLOBAL AND LOCAL PREPARATIONS/ PATIENT REPORTED OUTCOMES/ QOL AND CLINICAL /REGULATORY WORK Company Drug HEOR Value Propositions HTA Submissions Patient Reported Outcomes/ Quality of Life NDA/ Regulatory CSR CNS Ortho-McNeil Tapentadol US HCUP/ Premier PRO Janssen-Cilag Risperidone Australia/ published Canada/ Australia Health State Utilities Janssen-Cilag Risperidone Contra Australia Australia AstraZeneca Quetiapine Canada/ UK Canada Health State Utilities QUEST Trial Eisai Perampanel Global Global Health State Utilities GSK Lamotrigine US BMS Aripiprazole US/ Pharmerit data Cardiovascular Sankyo Olmesartan US/ Managed care data US-AMCP CS866-306 Daichii-Sankyo Olmesartan US/ Germany/ EU-5 CS866-411 BMS Irbesartan Global Global Multiple Trials Sanofi/BMS Irbesartan Europe Nycomed Olmesartan Norway Sanofi Ramapril Australia Abbott Niacin Australia Daichii-Sankyo Colesavelam US US AMCP Servier Ivabradine Global Australia Atherosclerosis Sanofi/ BMS Clopidogrel Global Global CAPRIE Sanofi/ BMS Clopidogrel Australia (ACS)
  2. 2. Endocrinology Sanofi Insulin Glargine Australia Australia/ US Sanofi U300 US/ UK Daichii-Sankyo Colesavelam US WEL 301, 302, 303 Oncology AstraZeneca Anastrozole Canada/ UK EORTC/ Health State Utilities AstraZeneca Zoladex Canada/ UK EORTC/ Health State Utilities AstraZeneca Faslodex Global EORTC BMS Dasatinib US Merck Pembrolizumab Global Eisai Eribulin Global Global EORTC FDA/ EMA Eisai Lenvatinib Global Eisai Farlatuzamab EORTC FDA/ EMA Sanofi Taxotere Australia Health State Utilities Rheumatology BMS Abatacept US Indirect Economics Respiratory AstraZeneca Zafirlukast Canada ASUI